IMCI is a pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach.
IMCI has developed a precise and effective dose together with an easy-to-use administration, suitable for any patient population at any time and place via its iCann medicinal cannabis platform.
IMCI research and development is based on an Israeli leading academic research institution in collaboration with established Israeli pharmaceutical providers which together with its team members, possess a proven track record in developing innovative cannabis-based medications.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Amsterdam, Nl
- ad****@****-bv.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- imci-bv.com
- Keywords
- Gan Yavne.
- HQ
- Amsterdam
Imci Pharmaceuticals Questions
Imci Pharmaceuticals's website is imci-bv.com
Imci Pharmaceuticals's LinkedIn profile is https://nl.linkedin.com/company/imci-pharmaceuticals
Imci Pharmaceuticals has
6 employees.
View email and phone details for 6
employees at Imci Pharmaceuticals.
Imci Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Imci Pharmaceuticals's top competitors are
Pinenanda,
Arava Power Company,
Rygo - Energy,
Smart Tech,
Paz Group פז כלכלה והנדסה,
Gsk,
Octapharma,
Proveca Ltd,
Arthrogen B.v.,
Valens Semiconductor.
Imci Pharmaceuticals's support email address is admin@imci-bv.com
Imci Pharmaceuticals's categories are Pharmaceutical Manufacturing
Imci Pharmaceuticals's founding year is 2018
